Edwards Lifesciences Corp
Change company Symbol lookup
Select an option...
EW Edwards Lifesciences Corp
COTY Coty Inc
MRNA Moderna Inc
BAC Bank of America Corp
NIO NIO Inc
IO ION Geophysical Corp
PRU Prudential Financial Inc
HAWEM Hawaiian Electric Company Inc
CCFN CCFNB Bancorp Inc
WYNN Wynn Resorts Ltd
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Closing Price
$83.10
Day's Change
-0.87 (-1.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
84.35
Day's Low
82.71
Volume
(Average)
Volume:
2,641,873

10-day average volume:
2,746,926
2,641,873

EW's position in the Health Care Equipment & Supplies industry

Industry PeersEWBDXBSXIDXXBAX

Summary

Company ProfileEdwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in...
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic...
Go to BDX summary
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven...
Go to BSX summary
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company...
Go to IDXX summary
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business...
Go to BAX summary
52-Week Change

VS. INDUSTRY
17.06%
-0.63%
2.27%
107.94%
-7.81%
Market Cap

VS. INDUSTRY
$51.9B
$70.1B
$55.0B
$44.4B
$39.2B
Beta

VS. INDUSTRY
1.0
0.8
0.9
0.9
0.7
Dividend Yield

VS. INDUSTRY
--
1.38%
--
--
1.26%
P/E (TTM, GAAP)

VS. INDUSTRY
64.39x
46.35x
--
77.53x
36.45x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$4.4B
$18.2B
$9.9B
$2.7B
$11.7B
Profit Margin

VS. INDUSTRY
18.77%
8.79%
-0.83%
21.51%
9.51%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
11.68%
-4.10%
--
26.74%
24.39%
Revenue Growth (TTM)

VS. INDUSTRY
0.88%
4.92%
-7.65%
12.45%
2.74%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.